BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25395875)

  • 1. Deriving a preference-based utility measure for cancer patients from the European Organisation for the Research and Treatment of Cancer's Quality of Life Questionnaire C30: a confirmatory versus exploratory approach.
    Costa DS; Aaronson NK; Fayers PM; Grimison PS; Janda M; Pallant JF; Rowen D; Velikova G; Viney R; Young TA; King MT
    Patient Relat Outcome Meas; 2014; 5():119-29. PubMed ID: 25395875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30.
    King MT; Costa DS; Aaronson NK; Brazier JE; Cella DF; Fayers PM; Grimison P; Janda M; Kemmler G; Norman R; Pickard AS; Rowen D; Velikova G; Young TA; Viney R
    Qual Life Res; 2016 Mar; 25(3):625-36. PubMed ID: 26790428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing the Breast Utility Instrument, a preference-based instrument to measure health-related quality of life in women with breast cancer: Confirmatory factor analysis of the EORTC QLQ-C30 and BR45 to establish dimensions.
    Tsui TCO; Trudeau M; Mitsakakis N; Torres S; Bremner KE; Kim D; Davis AM; Krahn MD
    PLoS One; 2022; 17(2):e0262635. PubMed ID: 35120148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Underlying dimensions of the EORTC QLQ-C30 in a Cuban population of patients with advanced non-small cell lung cancer.
    Viada C; Bouza C; Fors M; Frías A; Alvarez M; García L; Wilkinson B; Rodríguez C; Crombet T; Ballesteros J
    Qual Life Res; 2020 Dec; 29(12):3441-3448. PubMed ID: 33136243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deriving a Preference-Based Measure for Myelofibrosis from the EORTC QLQ-C30 and the MF-SAF.
    Mukuria C; Rowen D; Brazier JE; Young TA; Nafees B
    Value Health; 2015 Sep; 18(6):846-55. PubMed ID: 26409613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the EORTC QLQ-BM22 Module Using Rasch Modeling and Confirmatory Factor Analysis across Countries: a Comprehensive Psychometric Evaluation in Patients with Bone Metastases.
    Lin CY; Pakpour AH
    Asian Pac J Cancer Prev; 2016; 17(3):1405-10. PubMed ID: 27039780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing the Breast Utility Instrument to Measure Health-Related Quality-of-Life Preferences in Patients with Breast Cancer: Selecting the Item for Each Dimension.
    Tsui TCO; Trudeau ME; Mitsakakis N; Krahn MD; Davis AM
    MDM Policy Pract; 2022; 7(2):23814683221142267. PubMed ID: 36532295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese value set for the EORTC QLU-C10D: A multi-attribute utility instrument based on the EORTC QLQ-C30 cancer-specific quality-of-life questionnaire.
    Shiroiwa T; King MT; Norman R; Müller F; Campbell R; Kemmler G; Murata T; Shimozuma K; Fukuda T
    Qual Life Res; 2024 Jul; 33(7):1865-1879. PubMed ID: 38724771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do patients consider computer-adaptive measures more appropriate than static questionnaires?
    Gamper EM; Martini C; Petersen MA; Virgolini I; Holzner B; Giesinger JM
    J Patient Rep Outcomes; 2019 Jan; 3(1):7. PubMed ID: 30694417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies.
    Efficace F; Cottone F; Sommer K; Kieffer J; Aaronson N; Fayers P; Groenvold M; Caocci G; Lo Coco F; Gaidano G; Niscola P; Baccarani M; Rosti G; Venditti A; Angelucci E; Fazi P; Vignetti M; Giesinger J
    Value Health; 2019 Nov; 22(11):1303-1310. PubMed ID: 31708068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deriving a preference-based measure for cancer using the EORTC QLQ-C30.
    Rowen D; Brazier J; Young T; Gaugris S; Craig BM; King MT; Velikova G
    Value Health; 2011; 14(5):721-31. PubMed ID: 21839411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Chinese version of the Perceived Stress Questionnaire: development and validation amongst medical students and workers.
    Meng R; Li J; Wang Z; Zhang D; Liu B; Luo Y; Hu Y; Yu C
    Health Qual Life Outcomes; 2020 Mar; 18(1):70. PubMed ID: 32169070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The validity of EORTC QLQ-C30 fatigue scale in advanced cancer patients and cancer survivors.
    Knobel H; Loge JH; Brenne E; Fayers P; Hjermstad MJ; Kaasa S
    Palliat Med; 2003 Dec; 17(8):664-72. PubMed ID: 14694917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PROMIS-29 and EORTC QLQ-C30: an empirical investigation towards a common conception of health.
    Hartmann C; Fischer F; Klapproth CP; Röhle R; Rose M; Karsten MM
    Qual Life Res; 2023 Mar; 32(3):749-758. PubMed ID: 36617606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.
    Wallwiener M; Matthies L; Simoes E; Keilmann L; Hartkopf AD; Sokolov AN; Walter CB; Sickenberger N; Wallwiener S; Feisst M; Gass P; Fasching PA; Lux MP; Wallwiener D; Taran FA; Rom J; Schneeweiss A; Graf J; Brucker SY
    J Med Internet Res; 2017 Sep; 19(9):e322. PubMed ID: 28912116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.
    Wong CK; Lam CL; Wan YF; Rowen D
    Value Health; 2013; 16(2):373-84. PubMed ID: 23538190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life around the time of diagnosis in patients with bladder cancer.
    Yu EY; Nekeman D; Billingham LJ; James ND; Cheng KK; Bryan RT; Wesselius A; Zeegers MP
    BJU Int; 2019 Dec; 124(6):984-991. PubMed ID: 31077532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimensionality and Measurement Invariance of the Italian Version of the EORTC QLQ-C30 in Postoperative Lung Cancer Patients.
    Marzorati C; Monzani D; Mazzocco K; Pavan F; Monturano M; Pravettoni G
    Front Psychol; 2019; 10():2147. PubMed ID: 31649573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consistency matters: measurement invariance of the EORTC QLQ-C30 questionnaire in patients with hematologic malignancies.
    Sommer K; Cottone F; Aaronson NK; Fayers P; Fazi P; Rosti G; Angelucci E; Gaidano G; Venditti A; Voso MT; Baccarani M; Vignetti M; Efficace F
    Qual Life Res; 2020 Mar; 29(3):815-823. PubMed ID: 31782016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of the European Organisation for Research and Treatment of Cancer quality of life questionnaire module for older people with cancer: The EORTC QLQ-ELD15.
    Johnson C; Fitzsimmons D; Gilbert J; Arrarras JI; Hammerlid E; Bredart A; Ozmen M; Dilektasli E; Coolbrandt A; Kenis C; Young T; Chow E; Venkitaraman R; Howse F; George S; O'Connor S; Yadegarfar G;
    Eur J Cancer; 2010 Aug; 46(12):2242-52. PubMed ID: 20580993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.